108 related articles for article (PubMed ID: 38763511)
1. Imbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy.
Launay N; Lopez-Erauskin J; Bianchi P; Guha S; Parameswaran J; Coppa A; Torreni L; Schlüter A; Fourcade S; Paredes-Fuentes AJ; Artuch R; Casasnovas C; Ruiz M; Pujol A
Brain; 2024 Jun; 147(6):2069-2084. PubMed ID: 38763511
[TBL] [Abstract][Full Text] [Related]
2. The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy.
Coppa A; Guha S; Fourcade S; Parameswaran J; Ruiz M; Moser AB; Schlüter A; Murphy MP; Lizcano JM; Miranda-Vizuete A; Dalfó E; Pujol A
Free Radic Biol Med; 2020 May; 152():797-809. PubMed ID: 32017990
[TBL] [Abstract][Full Text] [Related]
3. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
[TBL] [Abstract][Full Text] [Related]
4. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
Singh J; Khan M; Singh I
J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
[TBL] [Abstract][Full Text] [Related]
5. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
[TBL] [Abstract][Full Text] [Related]
6. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
7. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
Baarine M; Beeson C; Singh A; Singh I
J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
[TBL] [Abstract][Full Text] [Related]
8. Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy.
McGuinness MC; Lu JF; Zhang HP; Dong GX; Heinzer AK; Watkins PA; Powers J; Smith KD
Mol Cell Biol; 2003 Jan; 23(2):744-53. PubMed ID: 12509471
[TBL] [Abstract][Full Text] [Related]
9. Beneficial Effects of the Direct AMP-Kinase Activator PXL770 in In Vitro and In Vivo Models of X-Linked Adrenoleukodystrophy.
Monternier PA; Parasar P; Theurey P; Gluais Dagorn P; Kaur N; Nagaraja TN; Fouqueray P; Bolze S; Moller DE; Singh J; Hallakou-Bozec S
J Pharmacol Exp Ther; 2022 Aug; 382(2):208-222. PubMed ID: 35764327
[TBL] [Abstract][Full Text] [Related]
10. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
Kruska N; Schönfeld P; Pujol A; Reiser G
Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
[TBL] [Abstract][Full Text] [Related]
11. Case report of dysregulation of primary bile acid synthesis in a family with X-linked adrenoleukodystrophy.
Płatek T; Orso E; Zapała B; Polus A; Kieć-Wilk B; Piwowar M; Chojnacka M; Ciałowicz U; Malczewska-Malec M; Schmitz G; Solnica B; Dembińska-Kieć A
Medicine (Baltimore); 2018 Dec; 97(49):e13353. PubMed ID: 30544401
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.
Singh J; Khan M; Singh I
Biochim Biophys Acta; 2013 Apr; 1831(4):747-58. PubMed ID: 23318275
[TBL] [Abstract][Full Text] [Related]
13. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S
Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency.
Oezen I; Rossmanith W; Forss-Petter S; Kemp S; Voigtländer T; Moser-Thier K; Wanders RJ; Bittner RE; Berger J
Hum Mol Genet; 2005 May; 14(9):1127-37. PubMed ID: 15772093
[TBL] [Abstract][Full Text] [Related]
15. Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy.
Raas Q; van de Beek MC; Forss-Petter S; Dijkstra IM; Deschiffart A; Freshner BC; Stevenson TJ; Jaspers YR; Nagtzaam L; Wanders RJ; van Weeghel M; Engelen-Lee JY; Engelen M; Eichler F; Berger J; Bonkowsky JL; Kemp S
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690217
[TBL] [Abstract][Full Text] [Related]
16. Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model.
Ranea-Robles P; Galino J; Espinosa L; Schlüter A; Ruiz M; Calingasan NY; Villarroya F; Naudí A; Pamplona R; Ferrer I; Beal MF; Portero-Otín M; Fourcade S; Pujol A
Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12747. PubMed ID: 34237158
[TBL] [Abstract][Full Text] [Related]
17. ABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis.
Buda A; Forss-Petter S; Hua R; Jaspers Y; Lassnig M; Waidhofer-Söllner P; Kemp S; Kim P; Weinhofer I; Berger J
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759733
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of deuterium-stabilized (R)-pioglitazone-PXL065-for X-linked adrenoleukodystrophy.
Monternier PA; Singh J; Parasar P; Theurey P; DeWitt S; Jacques V; Klett E; Kaur N; Nagaraja TN; Moller DE; Hallakou-Bozec S
J Inherit Metab Dis; 2022 Jul; 45(4):832-847. PubMed ID: 35510808
[TBL] [Abstract][Full Text] [Related]
19. ABCD1 and X-linked adrenoleukodystrophy: A disease with a markedly variable phenotype showing conserved neurobiology in animal models.
Manor J; Chung H; Bhagwat PK; Wangler MF
J Neurosci Res; 2021 Dec; 99(12):3170-3181. PubMed ID: 34716609
[TBL] [Abstract][Full Text] [Related]
20. Biochemical Studies in Fibroblasts to Interpret Variants of Unknown Significance in the
van de Stadt SIW; Mooyer PAW; Dijkstra IME; Dekker CJM; Vats D; Vera M; Ruzhnikov MRZ; van Haren K; Tang N; Koop K; Willemsen MA; Hui J; Vaz FM; Ebberink MS; Engelen M; Kemp S; Ferdinandusse S
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
